SCHEMBL13232139

SCHEMBL13232139

CC(=O)CCC(F)(F)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
CYP2C19 P33261 1/20 0.42
HIF1A Q16665 1/20 0.42
PTPN1 P18031 1/20 0.41
CNR1 P21554 1/20 0.40
MAPT P10636 3/20 0.39
KMT2A Q03164 1/20 0.39
TSHR P16473 1/20 0.39
OPRM1 P35372 2/20 0.39
DRD3 P35462 2/20 0.39
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
CES1 P23141 2/20 0.38
KCNN4 O15554 1/20 0.38
S1PR4 O95977 1/20 0.38
LMNA P02545 1/20 0.38
S1PR1 P21453 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CYP1A2 P05177 1/20 0.38
HDAC3 O15379 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13851657 0.83 CYP2C19 (0.45) ALDH1A1CYP2C19HIF1APTPN1CNR1
SCHEMBL16369386 0.80 ALDH1A1 (0.48) ALDH1A1CYP2C19HIF1AMAPTKMT2A
SCHEMBL824939 0.79 KCNN4 (0.47) ALDH1A1CNR1MAPTKMT2ATSHR
SCHEMBL2011672 0.78 ALDH1A1 (0.46) ALDH1A1CYP2C19HIF1ACNR1KMT2A
SCHEMBL2008935 0.77 SMN1; SMN2 (0.55) ALDH1A1PTPN1KMT2ATSHRS1PR4
SCHEMBL2791920 0.75 ALDH1A1 (0.43) ALDH1A1CNR1TSHR
Benzylacetone SCHEMBL27750721 0.74 ALDH1A1 (0.72) ALDH1A1CYP2C19TSHRCES1CYP1A2
SCHEMBL1097922 0.74 TSHR (0.46) ALDH1A1CYP2C19PTPN1TSHRKCNN4
SCHEMBL2015017 0.74 TSHR (0.46) ALDH1A1CYP2C19HIF1APTPN1CNR1
SCHEMBL12723130 0.73 ALDH1A1 (0.46) ALDH1A1CYP2C19HIF1AMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100168161-A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR LABORATORIOS ALMIRALL, S.A. (ES) 2010-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168161-A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR ADRB2, ADRB1, ADRA2C ALDH1A1 434/4885CYP2C19 678/4885HIF1A 1307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.